Scancell
University of Derby-origin immunotherapy company developing cancer vaccine and antibody platforms.
Profile
Scancell gives Derby a serious life-science reference point in immuno-oncology and platform biotechnology. It is relevant for founders because it shows the long arc from academic research through intellectual property, clinical development, public markets and specialist investor communication.
Derby link
Originated from University of Derby research and remains part of the city’s life-science story.
Sectorhealthtech
Stagegrowth
FundingAIM-listed
Employees50+
Founded1997